COMMUNIQUÉS West-GlobeNewswire

Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product
20/03/2025
Transaction is part of the Company’s new corporate strategy to become a revenue generating biotech WARRINGTON, Pa., March 20, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM [...]
Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain
20/03/2025
Positive Interim Blinded Data Supports Advancement Toward Potential Pivotal Phase 3 Study PHOENIX, March 20, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (the “Company”), a clinical [...]
Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate
20/03/2025
REYOBIQ™ (rhenium Re 186 obisbemeda) continues to be under clinical investigation for Leptomeningeal Metastases (LM) and Recurrent Glioblastoma (GBM) HOUSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. ( [...]
XOMA Royalty Declares Quarterly Preferred Stock Dividends
20/03/2025
EMERYVILLE, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty’s Series A and [...]
Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans
20/03/2025
FDA priority review of pz-cel Biologics License Application (BLA) progressing with Prescription Drug User Fee Act (PDUFA) target action date of April 29, 2025 Launch preparations on track toward goal to treat first [...]
Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community
20/03/2025
Interactive Tool Harnesses Real-World Data to Visualize Burden of Disease in HCM and Advance Equitable Access to Care SOUTH SAN FRANCISCO, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: [...]
InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones
20/03/2025
Received European Commission approval for GOHIBIC® (vilobelimab) for the treatment of SARS-CoV-2-induced acute respiratory distress syndrome (ARDS) Achieved 30-patient recruitment milestone in Phase 3 vilobelimab trial [...]
Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
20/03/2025
Strategic transformation ongoing, positioning the Company as a focused leader in immunology and inflammatory diseases Highly differentiated, potentially curative immunotherapy for celiac disease (VTP-1000) in the clinic [...]
Clearside Biomedical’s Lead Clinical Program CLS-AX in Wet AMD and Suprachoroidal Delivery Platform Highlighted at the 2025 Wet AMD & Diabetic Eye Disease Summit
20/03/2025
- Post-Hoc Analyses Provide Comparative Data on Rescue Criteria and Intervention- Free Rates for Tyrosine Kinase Inhibitors (TKIs) in Wet AMD Development - - Unique Ability to Re-Dose CLS-AX vs Rescue Supports [...]
PurDentix Under Review: The Truth About PurDentix and Its Mineral Ritual for Oral Health
20/03/2025
AURORA, Colo., March 20, 2025 (GLOBE NEWSWIRE) -- PurDentix is quickly gaining a reputation as a transformational supplement in the field of oral health. For years, those suffering from inflamed gums, sensitive teeth, [...]
Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update
20/03/2025
Positive Results with Zervimesine (CT1812) in Phase 2 SHIMMER Dementia with Lewy Bodies (DLB) Phase 2 SHINE Data Show Dramatic Slowing of Cognitive Decline with Zervimesine in a Key Pre-specified Alzheimer’s Disease [...]
Koelis Announces Innovative Products at EAU 2025 enhancing MRI Fusion Biopsy Workflows and promoting Focal Therapy in Prostate Cancer
20/03/2025
GRENOBLE, France, March 20, 2025 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com ), a global leader and innovator in urology and prostate care, announced today it is attending its 17 th [...]
Amphista Therapeutics to present novel mechanism of action for the degradation of BRD9 using its proprietary Targeted Glue® technology at two key upcoming scientific conferences
20/03/2025
Amphista Therapeutics to present novel mechanism of action for the degradation of BRD9 using its proprietary Targeted Glue® technology at two key upcoming scientific conferences Oral presentations will detail the rapid [...]
Impacts to Paramedic Services Amid Tariff Disputes
20/03/2025
OTTAWA, Ontario, March 20, 2025 (GLOBE NEWSWIRE) -- The Paramedic Chiefs of Canada (PCC) are calling on the federal government to immediately exempt ambulances and their key life-saving medical equipment from the [...]
Intended Retirement of Independent Non-executive Directors and changes of composition of board committees
20/03/2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ” or the “Company”) (Nasdaq/AIM:HCM, HKEX:13) today announces that Mr Paul Rutherford Carter and [...]
NTG Nordic Transport Group acquires DTK
20/03/2025
Company announcement no. 5 – 25 20 March 2025 NTG Nordic Transport Group acquires DTK NTG Nordic Transport Group A/S (“NTG”) has signed an agreement to acquire 100% of the shares in Danish-based DTK BE Holding ApS (“DTK [...]
Northern Karelia Cooperative Society (PKO) has chosen Aino’s SaaS platform
20/03/2025
Northern Karelia Cooperative Society (PKO), a customer members owned cooperative, has chosen the Aino SaaS platform as part of an initiative to enhance workforce well-being and improve work ability management. PKO [...]
Notice convening the Annual General Meeting in BioPorto A/S
20/03/2025
20 March 2025 Announcement no. 7 Notice convening the Annual General Meeting in BioPorto A/S The Board of Directors hereby convenes the Annual General Meeting of BioPorto A/S (“BioPorto” or the “Company”) to be held on [...]
BioPorto announces the Annual Report for 2024
20/03/2025
March 20, 2025 Announcement no. 06 BioPorto announces the Annual Report for 2024 Copenhagen, Denmark, March 20, 2025, (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto or company) (CPH:BIOPOR), an in vitro diagnostics company [...]

Pages